De-Risking Investments in Medical Technology Innovation
Springer International Publishing (Verlag)
9783032150066 (ISBN)
- Noch nicht erschienen - erscheint am 22.02.2026
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
This book provides medical technology entrepreneurs and their investors with a decision-making methodology based on the scientific approach that maximizes their chances of success. It enriches the understanding of valuation for medical startups, proposing an approach that moves the focus from the sophistication of the forecasting and financial methodologies to the quantitative importance of high-quality business assumptions and the economic impact of each critical business decision. It also provides a complete set of visual, organized, and compelling mental maps tailored to the business of medical technology innovation; maps that visualize and link the medical venture s decision-making and prediction problems. Their use minimizes the probability of overlooking critical decision problems on the path to successful execution while connecting them through a sequential and hierarchical framework. Finally, the book provides practical, real-life examples of how the scientific approach to decision-making can be used in medical technology startups outside the clinical trial area. The reader is left with various sets of valuable and practical tools that can be individually applied.
Dr Luigi Negri is Founder and CEO for ThinKeen® Global Consulting (Miami, FL, USA) and Venture Partner of Obloo® Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups. In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions. These positions included VP of Northern & Central Europe for Becton Dickinson® (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care®.
Chapter 1:Introduction.- Chapter 2:The Vocabulary of Medical Ventures.- Chapter 3:Why Medical Innovation is so Difficult.- Chapter 4:Minimizing Decision-Making Biases.- Chapter 5:Decision-Making Using a Scientific Approach.- Chapter 6:Mapping Decision-Related Problems in Medical Innovations.- Chapter 7:Deep-Dive into the Mapping of Decision-Related Problems.- Chapter 8:Prioritizing Decision-Related Problems.
| Erscheint lt. Verlag | 11.5.2026 |
|---|---|
| Reihe/Serie | Springer Series in Healthcare Management and Innovation |
| Zusatzinfo | X, 239 p. 164 illus., 106 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| Wirtschaft | |
| Schlagworte | Decision Tree • FINANCIAL VIABILITY • Investment risk • Medical Startup Failure • Medical Technology Entrepreneurship • Medical Technology Startup Valuation • Valuation Precision and Accuracy |
| ISBN-13 | 9783032150066 / 9783032150066 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
